Full Text View
Tabular View
No Study Results Posted
Related Studies
An Effectiveness, Safety and Quality of Life Measures With Hydromorphone HCL, Dilaudid CR (Controlled Release)
This study has been completed.
Study NCT00399048   Information provided by Alza Corporation, DE, USA
First Received: November 10, 2006   Last Updated: July 10, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Osteoarthritis, Knee
Osteoarthritis, Hip
Additional conditions recognized in this trial
Osteoarthritis
More general conditions related to this trial
Arthritis
Joint Diseases
Musculoskeletal Diseases
Rheumatic Diseases
Interventions listed in this trial
OROS hydromorphone HCL ; OxyContin
Additional drug interventions recognized in this trial
Hydromorphone
Oxycodone
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Alza Corporation, DE, USA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services